Literature DB >> 20004446

Adenovirus-mediated siRNA targeting Mcl-1 gene increases radiosensitivity of pancreatic carcinoma cells in vitro and in vivo.

Xiang Guoan1, Wang Hanning, Chen Kaiyun, Liu Hao.   

Abstract

BACKGROUND: Myeloid cell leukemia-1 (Mcl-1), an anti-apoptotic member of the B cell lymphoma/leukemia-2 (Bcl-2) family, has been shown to be involved in apoptosis and the cell cycle. Mcl-1 is overexpressed in many malignancies, including pancreatic cancer. The aim of this study was to investigate the effect of siRNA targeted against Mcl-1 on the radiosensitivity of human pancreatic carcinoma cells.
METHODS: In 3 pancreatic cancer cell lines, the expression of Mcl-1 mRNA was determined by RT-PCR assay, and the dose-dependent cytotoxicity of radiation was also assessed. Furthermore, the effects of adenovirus-mediated siRNA targeted against Mcl-1 on radiosensitivity of PANC-1 cells both in vitro and in vivo were evaluated.
RESULTS: Pancreatic cancer cells showed various levels of Mcl-1 mRNA that were correlated with the radiosensitivity of tumor cells. AdU6/shMcl-1 significantly downregulated the expression of Mcl-1 gene in PANC-1 cells, the most radioresistant cell line. Furthermore, Mcl-1 downregulation could significantly enhance radiosensitivity of PANC-1 cells in vitro and in vivo. The mechanism might be correlated with apoptosis enhancement by activating celluar caspase-3.
CONCLUSION: Mcl-1 might be a therapeutic target for radiosensitization of pancreatic carcinoma cells. Adenovirus-mediated siRNA targeting of Mcl-1 could enhance the radiosensitivity of pancreatic cancer cells both in vitro and in vivo, and thus might be a potential strategy for ameliorating cancer. Copyright 2010 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20004446     DOI: 10.1016/j.surg.2009.10.033

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  18 in total

1.  Pancreatic Cancer Combination Therapy Using a BH3 Mimetic and a Synthetic Tetracycline.

Authors:  Bridget A Quinn; Rupesh Dash; Siddik Sarkar; Belal Azab; Praveen Bhoopathi; Swadesh K Das; Luni Emdad; Jun Wei; Maurizio Pellecchia; Devanand Sarkar; Paul B Fisher
Journal:  Cancer Res       Date:  2015-06-01       Impact factor: 12.701

2.  A novel small-molecule inhibitor of mcl-1 blocks pancreatic cancer growth in vitro and in vivo.

Authors:  Fardokht Abulwerdi; Chenzhong Liao; Meilan Liu; Asfar S Azmi; Amro Aboukameel; Ahmed S A Mady; Thippeswamy Gulappa; Tomasz Cierpicki; Scott Owens; Tao Zhang; Duxin Sun; Jeanne A Stuckey; Ramzi M Mohammad; Zaneta Nikolovska-Coleska
Journal:  Mol Cancer Ther       Date:  2013-09-09       Impact factor: 6.261

Review 3.  The role of HTS in drug discovery at the University of Michigan.

Authors:  Martha J Larsen; Scott D Larsen; Andrew Fribley; Jolanta Grembecka; Kristoff Homan; Anna Mapp; Andrew Haak; Zaneta Nikolovska-Coleska; Jeanne A Stuckey; Duxin Sun; David H Sherman
Journal:  Comb Chem High Throughput Screen       Date:  2014-03       Impact factor: 1.339

Review 4.  Baicalein--an intriguing therapeutic phytochemical in pancreatic cancer.

Authors:  Graham Donald; Kathleen Hertzer; Guido Eibl
Journal:  Curr Drug Targets       Date:  2012-12       Impact factor: 3.465

Review 5.  Biological determinants of radioresistance and their remediation in pancreatic cancer.

Authors:  Parthasarathy Seshacharyulu; Michael J Baine; Joshua J Souchek; Melanie Menning; Sukhwinder Kaur; Ying Yan; Michel M Ouellette; Maneesh Jain; Chi Lin; Surinder K Batra
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2017-02-27       Impact factor: 10.680

6.  Antiapoptotic signaling via MCL1 confers resistance to caspase-3-mediated apoptotic cell death in the pregnant human uterine myocyte.

Authors:  Alyssa Stephenson-Famy; Jason Marks; Arvind Suresh; Stanley N Caritis; Hygraiv Simhan; Pancharatnam Jeyasuria; Jennifer C Condon
Journal:  Mol Endocrinol       Date:  2011-12-22

7.  Baicalein, a component of Scutellaria baicalensis, induces apoptosis by Mcl-1 down-regulation in human pancreatic cancer cells.

Authors:  Hiroki Takahashi; Monica C Chen; Hung Pham; Eliane Angst; Jonathan C King; Jenny Park; Ethan Y Brovman; Hideyuki Ishiguro; Diane M Harris; Howard A Reber; Oscar J Hines; Anna S Gukovskaya; Vay Liang W Go; Guido Eibl
Journal:  Biochim Biophys Acta       Date:  2011-05-10

8.  Association of anti-apoptotic Mcl-1L isoform expression with radioresistance of oral squamous carcinoma cells.

Authors:  Vinayak C Palve; Tanuja R Teni
Journal:  Radiat Oncol       Date:  2012-08-08       Impact factor: 3.481

9.  A bioinformatics filtering strategy for identifying radiation response biomarker candidates.

Authors:  Jung Hun Oh; Harry P Wong; Xiaowei Wang; Joseph O Deasy
Journal:  PLoS One       Date:  2012-06-29       Impact factor: 3.240

10.  The synergistic effects of traditional Chinese herbs and radiotherapy for cancer treatment.

Authors:  Lili Jia; Shumei Ma; Xue Hou; Xin Wang; Abu Baker Layth Qased; Xuefei Sun; Nan Liang; Huicheng Li; Heqing Yi; Dejuan Kong; Xiaodong Liu; Feiyue Fan
Journal:  Oncol Lett       Date:  2013-03-12       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.